The Creon shortage in the UK might be a symptom of global manufacturing issues, but Brexit created layers of complexity, cost, and regulatory hurdles that make the UK supply chain more fragile and less resilient which has made the problem worse for British patients. www.bbc.co.uk/news/article....

submitted 3 days ago • 0 comments